Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. Sanyal AJ, Newsome PN, Kliers I, Ostergaard LH, et al. N Engl J Med 2025 Apr 30. doi: 10.1056/NEJMoa2413258.

Read + Share

Amedeo Smart

Independent Medical Education

Sanyal AJ, Newsome PN, Kliers I, Ostergaard LH, et al. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl J Med 2025 Apr 30. doi: 10.1056/NEJMoa2413258.
PMID: 40305708